humanized antibodies – image credits Wikipedia

 
NOVEMBER 2015 – Pradaxa patients may have a better chance of surviving emergency surgeries, due to a recent study using 5g of idarucizumab (humanized antibody fragments). In critical cases, such as patients with uncontrolled bleeding, intracranial hemmorrhage, or severe trauma following an automobile accident, there is a

NOVEMBER 2015 – Four trial dates are set for early 2017 for the consolidated multidistrict litigation (MDL) against Bayer AG and a Johnson and Johnson subsidiary regarding injuries sustained by Xarelto patients. U.S. District Judge Eldon Fallon in the Eastern District of Louisiana issued the order for trial dates of February 6, 2017 and March

 

NOVEMBER 2015 – On October 16, 2015, in the US District Court for the Western District of North Carolina, the federal jury ruled in favor of Boston Scientific Corp., in a case regarding the risks and dangers of transvaginal mesh (TVM). The Uphold TVM manufacturer was stated to have no liability for flaws in

 

NOVEMBER 2015 – Additional lawsuits filed this year in Ohio and Pennsylvania allege that the blood thinner drug Xarelto is causing serious injuries and death to patients nationwide. Xarelto has been proven to cause complications, such as: excessive bleeding, red or black stools, frequent nosebleeds, pink or brown urine, unexplained bruises, bruises that increase

 

NOVEMBER 2015 – Juries across the US have awarded numerous settlements to victims of defective transvaginal mesh (TVM) products this year alone. Thousands more women have filed claims, due to injuries and complications following TVM surgeries. Boston Scientific is one transvaginal mesh manufacturer who paid millions this year to victims. One jury took only

 

OCTOBER 2015 – Although there is still no antidote for Xarelto or Eliquis, the European Medicines Agency (EMA) is fast-tracking Praxbind as an antidote for the blood thinner Pradaxa. Pradaxa patients have been injured and dying due to the anticoagulant causing uncontrollable bleeding in emergencies. The life-threatening risk of uncontrolled bleeding is a constant